MASSACHUSETTS GENERAL HOSPITAL
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1811-01-01
- Employees
- -
- Market Cap
- -
Neuroendocrine Modulation of Metabolic Effects in Overweight Adolescents
- Conditions
- Obesity
- First Posted Date
- 2005-09-01
- Last Posted Date
- 2021-11-02
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 47
- Registration Number
- NCT00140842
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Effectiveness of a Computer Application in Improving Pulmonary Artery Catheter Waveform Interpretation
- Conditions
- Pulmonary Artery Catheter Waveform Interpretation
- Interventions
- Device: Web-based waveform interpretation guide
- First Posted Date
- 2005-08-30
- Last Posted Date
- 2014-06-30
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 55
- Registration Number
- NCT00138073
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Anastrozole Administration in Elderly Hypogonadal Men
- First Posted Date
- 2005-08-29
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 88
- Registration Number
- NCT00136695
- Locations
- 🇺🇸
General Clinical Research Center, Massachusetts General Hospital, Boston, Massachusetts, United States
A Safety and Efficacy Study of Alefacept in the Treatment of Moderate to Severe Erosive Mucosal Lichen Planus
- Conditions
- Lichen Planus
- Interventions
- Drug: Amevive (Alefacept)Drug: Placebo
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2009-02-12
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 13
- Registration Number
- NCT00135733
- Locations
- 🇺🇸
Clinical Unit for Research Trials in Skin, Boston, Massachusetts, United States
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
- Conditions
- Pemphigus Vulgaris
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2015-06-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 12
- Registration Number
- NCT00135720
- Locations
- 🇺🇸
Clinical Unit for Research Trials in Skin, Boston, Massachusetts, United States
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
- Conditions
- Growth Hormone Deficiency
- Interventions
- Drug: Placebo
- First Posted Date
- 2005-08-26
- Last Posted Date
- 2008-02-18
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 63
- Registration Number
- NCT00136032
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
Improving Pediatric Safety and Quality With Health Care Information Technology
- Conditions
- Medication ErrorsMedical Records Systems, ComputerizedPatient SafetyQuality Improvement
- Interventions
- Other: weight based dosing decision support
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2011-07-21
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 5420
- Registration Number
- NCT00134823
- Locations
- 🇺🇸
Massachusetts General Hospital/Partners HealthCare, Boston, Massachusetts, United States
Testing the Right Question Project (RQP) Health Education Strategy in a Mental Health Setting
- Conditions
- Diagnosis, Psychiatric
- Interventions
- Behavioral: RQP patient health education module
- First Posted Date
- 2005-08-25
- Last Posted Date
- 2016-06-03
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 231
- Registration Number
- NCT00134615
- Locations
- 🇺🇸
MGH Chelsea Healthcare Center, Chelsea, Massachusetts, United States
🇺🇸Windsor Street Health Center, Cambridge, Massachusetts, United States
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
- Conditions
- Multiple MyelomaMyelogenous LeukemiaNon-Hodgkin's LymphomaHodgkin's DiseaseLymphoblastic Leukemia
- First Posted Date
- 2005-08-23
- Last Posted Date
- 2016-07-25
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 32
- Registration Number
- NCT00133367
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
Growth Hormone, Cardiovascular Risk, and Visceral Adiposity
- Conditions
- Obesity
- Interventions
- Drug: Placebo Growth Hormone
- First Posted Date
- 2005-08-18
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- Massachusetts General Hospital
- Target Recruit Count
- 142
- Registration Number
- NCT00131378
- Locations
- 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States